BioGenes Has Developed Cellmid´s Midkine Blood Test and Report Manufacture of First Kits

Berlin, Germany, November 16, 2010 / b3c newswire / BioGenes GmbH, a supplier of GMP compliant immunoassay and antibody services, has developed and optimized the first ever fully validated ELISA protocol for Midkine detection in...[more]

BioGenes Says Generic HCP Assays Provide Insufficient Sensitivity

Berlin, Germany, April 14, 2010 / b3c newswire / BioGenes GmbH, a supplier of GMP-compliant immunoassays and antibodies, completed a study that documents the insufficient sensitivity of an ELISA-based generic host cell protein...[more]

Stable F&E Budgets help Biotech Suppliers Defy the Crisis

Weaknesses in product development and high research costs for pharmaceutical companies provide opportunities for biotech companies[more]

BioGenes as new designated partner in EU funded dementia project

Berlin, Germany, February 2, 2008 / b3c newswire / – BioGenes GmbH, a specialist in sophisticated antibody development, has been chosen as a new partner of cNEUPRO. cNEUPRO is a EU funded research project to analyse...[more]

Press Release 01/06 – 24 August 2006

BioGenes GmbH and VWR Announce a Strategic Alliance for sales[more]

Press Release 01/05 – 20 June 2005

BioGenes – antibody development with new technology platform[more]

Press Release 04/04 – 12 August 2004

BioGenes intensifies business activities in Asia[more]

Displaying results 1 to 7 out of 17
<< First < Previous 1-7 8-14 15-17 Next > Last >>